Publications by authors named "Lisa Edgerton"
Establishment of a pharmacist-led service for patients at high risk for opioid overdose.
Am J Health Syst Pharm
March 2018
Purpose: A program at a family medicine clinic to provide naloxone prescriptions in conjunction with education on naloxone use and opioid hazards to patients at risk for opioid overdose is described.
Summary: Consistent with a 2016 Centers for Disease Control and Prevention (CDC) guideline on opioid prescribing for chronic pain, a family medicine clinic implemented updated controlled substance agreements and medical record templates for documentation of pain management visits and established a pharmacist-led naloxone clinic. Chart reviews were performed to identify patients eligible for naloxone, as defined by the CDC guideline.
Incorporation of lean methodology into pharmacy residency programs.
Am J Health Syst Pharm
March 2017
Article Synopsis
- The implementation of lean methodology at New Hanover Regional Medical Center has been used to enhance pharmacy residency programs since 2014, following the hospital's adoption of a lean culture in 2010.
- Lean tools have been integrated into required competency areas, focusing on leadership, management, teaching, and education, allowing residents to participate actively in problem-solving and communication.
- The incorporation of lean practices has led to significant improvements in program management, quality processes, and communication, while also expanding leadership opportunities for pharmacy residents.
Article Synopsis
- - A 55-year-old woman with type 2 diabetes was initially treated with metformin, but switched to a combination of sitagliptin and glipizide due to liver issues, leading to some weight gain and a decrease in blood sugar levels over several months.
- - After adding exenatide to her treatment, she experienced significant improvements in blood glucose readings, with an HbA1c drop from 13.4% to 7.4% and a weight loss of 11 lb, despite no lifestyle changes.
- - The case suggests that using a combination of exenatide, sitagliptin, and glipizide can be an effective and safe approach for managing type 2 diabetes in